Class Action Law: Is Certification Denial The End Of The Road For Absent Plaintiffs?
This article was originally published in The Pink Sheet Daily
Supreme Court asks whether state courts can relitigate federal multidistrict decisions in a class-action case and whether plaintiffs' rights to a day in court are protected.
You may also be interested in...
The court will consider whether health care providers have the right to file suit to get drug manufacturers to enforce statutory requirements on drug pricing.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.